Skip to main content
Log in

Secreted Frizzled-related Protein 2 (SFRP2) is Highly Expressed in Canine Mammary Gland Tumors but not in Normal Mammary Glands

  • Published:
Breast Cancer Research and Treatment Aims and scope Submit manuscript

Abstract

Canine mammary gland tumor (MGT) is the commonest tumor in female dogs and a good animal model of human breast cancer. A group of newly identified genes encoding secreted frizzled-related proteins (SFRP) have been implicated in apoptosis regulation and tumorigenesis. Canine mammary tissues from 50 spontaneous MGTs and 10 normal mammary glands (MGs) were obtained from surgically excised specimens and analyzed for expression of SFRP2, β-catenin, and cyclin D1. By RT-PCR and in situ hybridization, SFRP2 gene was found abundantly expressed in neoplastic mammary tissues but not in normal mammary tissues, suggesting that SFRP2 may contribute as a tumor marker in canine MGTs. By immunohistochemical staining, the immunoreactivity of the SFRP2 protein was detected in more diverse areas than SFRP2 mRNA expression, including nuclei or/and cytoplasm and extracellular matrix of the tumor. In tumor masses, β-catenin lost its tight association with the membrane and diffused into the nucleus. The expression of β-catenin (79.4% positive) and cyclin D1 (71.4% positive) was also increased in MGTs. In the course of tumor progression, SFRP2 mRNA (p < 0.05) and β-catenin protein (p < 0.01) steadily increased but not in cyclin D1. The level of SFRP2 was linearly correlated with its downstream target β-catenin (p < 0.05), but not correlated with cyclin D1 (p < 0.5). As revealed in this study, the exclusive overexpression of SFRP2 in canine MGTs suggests that SFRP2 is a potential candidate gene for further investigation of mammary tumorigenesis and complex etiology of the canine model of mammary neoplasms.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References

  1. Nusse R, Varmus HE: Wnt genes. Cell 69: 1073–1087, 1992

    Google Scholar 

  2. Parr BA, McMahon AP: Wnt genes and vertebrate development. Genet Dev 4: 523–528, 1994

    Google Scholar 

  3. Moon RT, Brown JD, Torres M: WNTs modulate cell fate and behavior during vertebrate development. Trends Genet 13: 157–162, 1997

    Google Scholar 

  4. Gubb D, Garcia-Bellido A: A genetic analysis of the determination of cuticular polarity during development in Drosophila melanogaster. J Embryol Exp Morphol 68: 37–57, 1982

    Google Scholar 

  5. Bhanot P, Brink M, Samos CH, Hsieh JC, Wang Y, Macke JP, Andrew D, Nathans J, Nusse R: A new member of the frizzled family from Drosophila function as a Wingless receptor. Nature 382: 225–230, 1996

    Google Scholar 

  6. Finch PW, He X, Kelley MJ, Ñren A, Schaudies RP, Popescu NC, Rudikoff S, Aaronson SA, Varmus HE, Rubin JS: Puri-fication and molecular cloning of a secreted, frizzled-related antagonist of WNT action. Proc Natl Acad Sci USA 94: 6770–6775, 1997

    Google Scholar 

  7. Rattner A, Hsieh JC, Smallwood PM, Gilbert DJ, Copeland NG, Jenkins NA, Nathans J: A family of secreted proteins contains homology to the cysteine-rich ligand-binding domain of frizzled receptors. Proc Natl Acad Sci USA 94: 2859–2863, 1997

    Google Scholar 

  8. Melkonyan HS, Chang WC, Shapiro JP, Mahedevappa M, Fitzpatrick PA, Kiefer MC, Tomei LD, Urmansky SR: sARPs: a family of secreted apoptosis-related proteins. Proc Natl Acad Sci USA 94: 13636–13641, 1997

    Google Scholar 

  9. Wolf V, Ke G, Dharmarajan AM, Bielke W, Artuso L, Saurer S, Friis R: DDC-4, an apoptosis-associated gene, is a secreted frizzled relative. FEBS Lett 417: 385–389, 1997

    Google Scholar 

  10. Lin CT, Sargan DR: A method for generating subtractive cDNA libraries retaining clones containing repetitive elements. Nucl Acids Res 25: 4427–4428, 1997

    Google Scholar 

  11. Lin CT, Sargan DR: Generation and analysis of canine retinal ESTs: isolation and expression of retina-specific gene transcripts. Biochem Biophys Res Commun 282: 394–403, 2001

    Google Scholar 

  12. Lammers CH, D'Souza U, Qin ZH, Lee SH, Yajima S, Mouradian MM: Regulation of striatal dopamine receptors by estrogen. Synapse 34: 222–227, 1999

    Google Scholar 

  13. Cardone A, Angelini F, Varriale B: Autoregulation of estrogen and androgen receptor mRNAs and downregulation of androgen receptor mRNA by estrogen in primary cultures of lizard testis cells. Gen Comp Endocrinol 110: 227–236, 1998

    Google Scholar 

  14. Nickenig G, Baumer AT, Grohe C, Kahlert S, Strehlow K, Rosenkranz S, Stablein A, Beckers F, Smits JF, Daemen MJ, Vetter H, Bohm M: Estrogen modulates AT1 receptor gene expression in vitro and in vivo. Circulation 97: 2197–2201, 1998

    Google Scholar 

  15. Batra S, Al-Hijji J: Characterization of nitric oxide synthase activity in rabbit uterus and vagina: downregulation by estrogen. Life Sci 62: 2093–2100, 1998

    Google Scholar 

  16. Jones SE, Jomary C, Grist J, Stewart HJ, Neal MJ: Altered expression of secreted frizzled-related protein-2 in retinitis pigmentosa retinas. Invest Ophthalmol Vis Sci 41: 1297–1301, 2000

    Google Scholar 

  17. Roth W, Wild-Bode C, Platten M, Grimmel C, Melkonyan HS, Dichgans J, Weller M: Secreted frizzled-related proteins inhibit motility and promote growth of human malignant glioma cells. Oncogene 19: 4210–4220, 2000

    Google Scholar 

  18. Nerurkar VR, Chitale BV, Jalnapurkar BV, Naik SN, Lalitha VS: Comparative pathology of canine mammary tumors. J Comp Pathol 101: 389–397, 1989

    Google Scholar 

  19. Destexhe E, Lespagnard L, Degeyter M, Heymann R, Coignoul F: Immunohistochemical identification of myoepithelial, epithelial, and connective tissue cells in canine mammary tumors. Vet Pathol 30: 146–154, 1993

    Google Scholar 

  20. Donnay I, Rauis J, Devleeschouwer N, Wouters-Ballman P, Leclercq G, Verstegen J: Comparison of estrogen and progesterone receptor expression in normal and tumor mammary tissues from dogs. Am J Vet Res 56: 1188–1194, 1995

    Google Scholar 

  21. Middleton LP, Chen V, Perkins GH, Pinn V, Page D: Histopathology of breast cancer among African American women. Cancer 97(Suppl 1): 253–257, 2003

    Google Scholar 

  22. Martin PM, Cotard M, Mialot JP, Andre F, Raynaud JP: Animal models for hormone-dependent human breast cancer. Relationship between steroid receptor profiles in canine and feline mammary tumors and survival rate. Cancer Chemother Pharmacol 12: 13–17, 1984

    Google Scholar 

  23. Donnay I, Rauis J, Wouters-Ballman P, Devleeschouwer N, Leclercq G., Verstegen JP: Receptors for oestrogen, progesterone and epidermal growth factor in normal and tumorous canine mammary tissues. J Reprod Fertil 47: 501–512, 1993

    Google Scholar 

  24. Lee JL, Chang CJ, Chueh LL, Lin CT: Expression of secreted frizzled related protein 2 in a primary canine mammary tumor SFRP2 is highly expressed in canine MGTs 149 cell line: a candidate tumor marker for mammary tumor cells. In Vitro Cell Dev Biol-Anim 39: 357-364

  25. Remmele W, Schicketanz KH: Immunohistochemical determination of estrogen and progesterone receptor content in human breast cancer. Computer-assisted image analysis (QIC score) vs. subjective grading IRS. Pathol Res Pract 189: 862–866, 1993

    Google Scholar 

  26. Lin WC, Shen BJ, Tsay YG, Yen HC, Lee SC, Chang CJ: Transcriptional activation of C/EBPbeta gene by c-Jun and ATF2. DNA Cell Biol 21: 551–560, 2002

    Google Scholar 

  27. Chang CJ, Chen YL, Lee SC: Coactivator TIF1beta interacts with transcription factor C/EBPbeta and glucocorticoid receptor to induce alpha1-acid glycoprotein gene expression. Mol Cell Biol 18: 5880–5887, 1998

    Google Scholar 

  28. Sambrook J, Gritsch E, Maniatis T: Molecular Cloning: A Laboratory Manual. Cold Spring Harbor Laboratory, New York, 1989

    Google Scholar 

  29. Bergstein I, Brown AMC: In: Bow-cock AM (ed) Breast Cancer: Molecular Genetics, Pathogenesis and Therapeutics. Human Press, Totowa, NJ, 1999, pp 181–198

    Google Scholar 

  30. Morin PJ, Sparks AB, Korinek V, Barker N, Clevers H, Vogelstein B, Kinzler KW: Activation of â-catenin-Tcf signaling in colon cancer by mutations in α-catenin or APC. Science 275: 1787–1790, 1997

    Google Scholar 

  31. He TC, Sparks AB, Rago C, Hermeking H, Zawel L, da Costa LT, Morin PJ, Vogelstein B, Kinzler KW: Identification of c-MYC as a target of the APC pathway. Science 281: 1509–1512, 1998

    Google Scholar 

  32. Tetsu O, McCormick F: α-Catenin regulates expression of cyclin D1 in colon carcinoma cells. Nature 398: 422–426, 1999

    Google Scholar 

  33. Roose J, Huls G, van Beest M, Moerer P, van der Horn K, Goldschmeding R, Logtenberg T, Clevers H: Synergy between tumor suppressor APC and the â-catenin-Tcf4 target Tcf1. Science 285: 1923–1926, 1999

    Google Scholar 

  34. Ingvarsson S: Molecular genetics of breast cancer progression. Semin Cancer Bio 9: 277–288, 1999

    Google Scholar 

  35. Ross JS, Fletcher JA: HER-2/neu (c-erb-B2) gene and protein in breast cancer. Am J Clin Pathol 112: S53–S67, 1999

    Google Scholar 

  36. Simpson JF, Page DL: The p53 tumor suppressor gene in ductal carcinoma in situ of the breast. Am J Pathol 156: 5–6, 2000

    Google Scholar 

  37. Lin TP, Guzman RC, Osborn RC, Thordarson G, Nandi S: Role of endocrine, autocrine, and paracrine interactions in the development of mammary hyperplasia inWnt-1 transgenic mice. Cancer Res 52: 4413–4419, 1992

    Google Scholar 

  38. Chen S, Guttridge DC, You Z, Zhang Z, Fribley A, Mayo MW, Kitajewski J, Wang CY: Wnt-1 signaling inhibits apoptosis by activating â-catenin/T cell factor-mediated transcription. J Biol Chem 152: 87–96, 2001

    Google Scholar 

  39. Wang TC, Cardiff RD, Zukerburg L, Lees E, Arnold A, Schmidt EV: Mammary hyperplasia and carcinoma in MMTV-cyclin D1 transgenic mice. Nature 369: 669–671, 1994

    Google Scholar 

  40. Bodrug SE, Warner BJ, Bath ML, Lindeman GJ, Harris AW, Adams JM: Cyclin D1 transgene impedes lymphocyte maturation and collaborates in lymphomagenesis with the myc gene. EMBO J 13: 2124–2130, 1994

    Google Scholar 

  41. Bafico A, Gazit A, Pramila T, Finch PW, Yaniv A, Aaronson SA: Interaction of frizzled related protein (FRP) with wnt ligands and the frizzled receptor suggests alternative mechanisms for FRP inhibition of wnt signaling. J Biol Chem 274: 16180–16187, 1999

    Google Scholar 

  42. Xu W, D'Amore PA, Sokol SY: Functional and biochemical interactions of Wnts with FrzA, a secreted Wnt antagonist. Development 125: 4767–4776, 1998

    Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Rights and permissions

Reprints and permissions

About this article

Cite this article

Lee, JL., Chang, CJ., Wu, SY. et al. Secreted Frizzled-related Protein 2 (SFRP2) is Highly Expressed in Canine Mammary Gland Tumors but not in Normal Mammary Glands. Breast Cancer Res Treat 84, 139–149 (2004). https://doi.org/10.1023/B:BREA.0000018412.83348.ff

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1023/B:BREA.0000018412.83348.ff

Navigation